Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise-CISCO-21Randomized Controlled Trial Published on 2022-08-152022-10-05 Journal: Trials [Category] SARS, 임상, [키워드] Admission breathlessness cause chest pain Contact Controlled clinical trial COVID COVID-19 COVID-19 infection diagnosis of COVID-19 discharged Dyspnoea early treatment Effect Ethical approval ethics committee Exercise capacity fatigue frailty group Health Health status healthcare professionals hospital hospitalisation hospitalised Infection Intervention Long Long COVID National Health Service NHS participant Patient personalised physical physical activity Pragmatic prevention Primary outcome problem Quality of life questionnaire randomisation randomised randomised controlled trial REC recruitment Registered rehabilitation resistance resistance exercise SARS-CoV-2 secondary outcome spirometry Symptom syndrome therapy Two-arm usual care West [DOI] 10.1186/s13063-022-06632-y PMC 바로가기 [Article Type] Randomized Controlled Trial
The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021Observational Study Published on 2022-08-152022-10-04 Journal: The Medical journal of Australia [Category] 임상, [키워드] Active surveillance adjusted Administered adverse event anaphylaxis AstraZeneca BNT162b2 ChAdOx1 chronic inflammatory disease clinics Cohort Controlled COVID-19 COVID-19 vaccination COVID-19 vaccine demographic characteristics dose drug-related side effects and adverse reactions eight fatigue headache immunodeficiency Medical conditions men myalgia National obesity outcome Pain Pfizer-BioNTech proportion Prospective reported reported symptoms safety profile secondary setting Seven Side effect study period Surveillance underlying conditions vaccination Vaccine women [DOI] 10.5694/mja2.51619 PMC 바로가기 [Article Type] Observational Study
Mobility was a significant determinant of reported COVID-19 incidence during the Omicron Surge in the most populous U.S. Counties이동성은 미국에서 가장 인구가 많은 카운티에서 Omicron Surge 동안 보고된 COVID-19 발병의 중요한 결정 요인이었습니다.Article Published on 2022-08-152022-09-11 Journal: BMC Infectious Diseases [Category] SARS, 변종, [키워드] 95% CI 95% confidence interval categories Cohort contrary Course covariates COVID-19 COVID-19 incidence cross-sectional analysis cumulative declined Epidemics exhibiting fatigue fraction Google Google mobility reports household size humans Immune escape incidence infect Infection intrinsic Mobility omicron Omicron variant peaked Perceived risk Principal component principal component analysis principal components question reported risk-mitigating behavior. robustness SARS-CoV-2 Significant susceptible individual susceptible individuals vaccination variant widespread [DOI] 10.1186/s12879-022-07666-y PMC 바로가기 [Article Type] Article
Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)COVID-19의 긴 COVID/급성 후유증(PASC)을 가진 개인의 증상, 동반질환, 섬유소 아밀로이드 미세응고 및 혈소판 병리의 유병률Article Published on 2022-08-062022-09-11 Journal: Cardiovascular Diabetology [Category] SARS, 진단, 치료기술, [키워드] accompanied acute COVID-19 African amyloid Amyloid fibrin(ogen) analysed Atypical balance blood sample Blood samples Brain capillary cardiovascular disease cholesterol Clinical studies clinical study Clinical treatment co-morbidities Comorbidities Comorbidity comparable Concentration controlled clinical studies coronavirus coronavirus 2019 disease COVID-19 COVID-19 severity determine diabetes Diabetes Mellitus Diagnostic method Diversity dyslipidaemia Early detection effective Efficacy endotheliopathy fatigue female FIBRIN Fluorescence fluorescence microscopy foci Gender Hyperactivated platelets hypertension individual inhibit joint Long Long COVID/PASC morbidities muscle pains ogen PASC pathology Patient patients Platelet platelet hyperactivation Platelets platform provide reducing registry removal reported reversal SARS-COV-2 infection scoring system Shortness of breath South Symptom Symptoms tissues Transport Treatment type 2 diabete Type 2 diabetes mellitus [DOI] 10.1186/s12933-022-01579-5 PMC 바로가기 [Article Type] Article
COVID-19 Outbreak: Understanding Moral-Distress Experiences Faced by Healthcare Workers in British Columbia, CanadaCOVID-19 발병: 캐나다 브리티시컬럼비아주 의료 종사자들이 겪는 도덕적 고통 경험 이해하기Article Published on 2022-08-062022-09-11 Journal: International Journal of Environmental Research an [Category] 유전자 메커니즘, [키워드] Anxiety Canada Care caused coping strategies COVID-19 COVID-19 pandemic distress ethical dilemmas experience fatigue Formal friends HCW HCWs healthcare worker Healthcare workers help helplessness identify intrinsic mechanisms mental health methodology Moral distress pandemic Patient provided Research resources respondent risk self-care Sleep disturbances Stage Stress Support thematic analysis understanding worker [DOI] 10.3390/ijerph19159701 PMC 바로가기 [Article Type] Article
Measurements of Anti-SARS-CoV-2 Antibody Levels after Vaccination Using a SH-SAW BiosensorSH-SAW 바이오센서를 이용한 예방접종 후 Anti-SARS-CoV-2 항체 수치 측정Article Published on 2022-08-042022-09-12 Journal: Biosensors [Category] SARS, 진단, [키워드] adenovirus vaccine adverse effect Anti-SARS-CoV-2 S antibody antibody concentration biosensor Blood Blood clots BNT chronic disease coated with Concentration COVID-19 pandemic cut-off diagnostic system fatigue first vaccination Health help in vitro increasingly induce Level Local measurement Moderna MONITOR mRNA vaccines myocarditis Pain pandemic Patient prevalence of COVID-19 Prevent Protein reduce SARS-CoV-2 SARS-CoV-2 spike protein second vaccination SH-SAW biosensor vaccination Vaccinations Vaccine was determined [DOI] 10.3390/bios12080599 PMC 바로가기 [Article Type] Article
Predictors of chronic COVID-19 symptoms in a community-based cohort of adults지역사회 기반 성인 코호트의 만성 COVID-19 증상 예측자Observational Study Published on 2022-08-042022-09-11 Journal: PLoS ONE [Category] SARS, 임상, 진단, 치료법, [키워드] acute COVID-19 acute disease ambulatory Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG antibody Antibody testing changes in Chi-square chronic class Cluster Cohort Community-based cohort COVID-19 COVID-19 infection COVID-19 symptom COVID-19 symptoms demographics disease fatigue female Follow-up headache Headaches highest identify IgG antibody IgG levels individual Infection joint Latent less males median muscle nucleocapsid protein IgG observational study Occurrence participant PASC positive predictor proportion Rate responses risk SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV2 infection severity Sex significantly higher Symptom Symptomatology Symptoms Taste was performed was used weakness [DOI] 10.1371/journal.pone.0271310 PMC 바로가기 [Article Type] Observational Study
Serum of Post-COVID-19 Syndrome Patients with or without ME/CFS Differentially Affects Endothelial Cell Function In VitroME/CFS가 있거나 없는 포스트 코로나19 증후군 환자의 혈청은 체외 내피 세포 기능에 차등적으로 영향을 미칩니다Article Published on 2022-08-022022-09-11 Journal: Cells [Category] 바이오마커, [키워드] Activation analysed Angiogenesis autoantibodies autoantibody binding Cell chronic fatigue syndrome compensatory mechanism COVID-19 Cytokines demonstrated develop Diagnostic Criteria dysregulated Effect Encephalomyelitis endothelial endothelial cells Endothelial dysfunction fatigue fatigue syndrome flow cytometry function functional groups healthy control healthy controls hypothesise in vitro investigated involved marker mechanism molecules Myalgic encephalomyelitis/chronic fatigue syndrome nitric oxide Patient patient cohort patient group patient groups patients post-COVID syndrome profile promoted proportion reduced screened secretion sera serum serum cytokines significantly significantly increased small molecule Small molecules syndrome vascular remodelling was measured while [DOI] 10.3390/cells11152376 PMC 바로가기 [Article Type] Article
Fatigue In Covid-19 Survivors: The Potential Impact Of A Nutritional Supplement On Muscle Strength And FunctionResearch article Published on 2022-08-012022-10-05 Journal: Clinical nutrition ESPEN [Category] 바이오마커, [키워드] acute COVID-19 affected aging All participant amino acids Analysis analyzed blood biochemistry Body body composition Chair stand test COVID-19 enrolled evaluate evaluated fatigue ferritin level ferritin levels function hand hand grip strength Health Health status Hospitalized Impact invasive ventilation laboratory parameter Long COVID long-lasting low-flow oxygen supplementation Minerals muscle Muscle function Muscle strength NIV Noninvasive ventilation not significant Older parameters participant Patient performed physical Potential Quality of life reduced reduction repetition Result Rome strength strength test survivor Survivors Tolerance Visual Analogue Scale vitamins was obtained [DOI] 10.1016/j.clnesp.2022.08.029 [Article Type] Research article
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trialChAdOx1 nCoV-19 또는 BNT162b2 2회 접종 및 BNT162b2(COV-BOOST) 3차 접종 후 4차 접종으로 제공된 BNT162b2 및 mRNA-1273 COVID-19 백신의 안전성, 면역원성 및 반응성: 다기관, 맹검, 단계 2, 무작위 시험Clinical Trial Published on 2022-08-012022-09-11 Journal: The Lancet. Infectious Diseases [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, [키워드] 1:1 95% CI adverse event All participants analysed anti-spike protein IgG assigned blinded block size BNT162b2 boost booster Booster vaccine cellular Cellular and humoral immunity Cellular immune response ChAdOx1 nCoV-19 computer-generated Concentration Controlled trial country COV-BOOST COVID-19 COVID-19 vaccine COVID-19 vaccines dose doses Effectiveness ELISA ELISPOT Endpoint enrolled fatigue female Fold change Fold changes force geometric geometric mean groups Humoral immunity immunogenicity Intramuscular injection IQR ISRCTN Laboratory Local male median age median interval Moderna modified intention-to-treat mRNA mRNA-1273 mRNA-1273 booster mRNA-1273 COVID-19 vaccine multicentre of BNT162b2 outcome participant peak per-protocol population Pfizer-BioNTech Phase 2 random randomisation list randomised controlled trial Randomised trial Randomly reactogenicity receive Registered reported representing response Safety SARS-CoV-2 screened Serious Adverse Event seronegative participant seronegative participants serostatus Seven significant increase statistician T-cell Response T-cell responses Task Force the vaccine the vaccines titre treatment allocation Trial upper arm Vaccine variant were assessed wild-type [DOI] 10.1016/S1473-3099(22)00271-7 PMC 바로가기 [Article Type] Clinical Trial